Tapewire

NYSE · USD

MOH

MOLINA HEALTHCARE, INC.

Export transactions ↓
Tapewire entity
3504
SEC CIK
0001179929
Parsed reports
704

Last 12 months

Inside the activity.

1 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202610
Mar 202601
Apr 202600
May 202602
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 01, 2024 Filed Jul 2, 2024 20:58 UTC
WOLF DALE BDirector
GrantCommon Stock 188 $292.16 $54,926.08
Disclosure

SEC source: 0001179929-24-000114 · wk-form4_1719953916.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,191

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:57 UTC GrantCommon Stock 188 $292.16 $54,926.08
Disclosure

SEC source: 0001179929-24-000113 · wk-form4_1719953849.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 19,025

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:55 UTC GrantCommon Stock 188 $292.16 $54,926.08
Disclosure

SEC source: 0001179929-24-000111 · wk-form4_1719953752.xml · nonDerivative · entry 1

COOPERMAN DANIEL · CIK 0001205008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,977

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:55 UTC
ROMNEY RONNADirector
GrantCommon Stock 188 $292.16 $54,926.08
Disclosure

SEC source: 0001179929-24-000110 · wk-form4_1719953707.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,133

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on July 1, 2024, was $292.16, which resulted in a grant of 188 shares.

F3 · price: Represents the closing price of the Issuer's common stock on July 1, 2024.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 20:54 UTC
Bacon DebraEVP, Medicaid
Tax withholdingCommon Stock 184 $292.16 $53,757.44
Disclosure

SEC source: 0001179929-24-000109 · wk-form4_1719953665.xml · nonDerivative · entry 2

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,505

F3 · price: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 531 shares on July 1, 2024.

F4 · balance_after: The shares vest as follows: 1,231 shares on January 1, 2025; 1,249 shares on March 1, 2025; 530 shares on July 1, 2025; 1,003 shares on March 1, 2026; 529 shares on July 1, 2026; and 757 shares on March 1, 2027. The remaining shares are vested.

Read SEC document
June 28, 2024 Filed Jul 2, 2024 20:54 UTC
Bacon DebraEVP, Medicaid
GrantCommon Stock 13 $252.71 $3,285.23
Disclosure

SEC source: 0001179929-24-000109 · wk-form4_1719953665.xml · nonDerivative · entry 1

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,689

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: In accordance with the ESPP provisions, the purchase price is 85% of the closing price of the Issuer's common stock on June 28, 2024 of $297.30 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2024, the first date of the ESPP offering period, and (ii) June 28, 2024, the last trading day of the offering period).

Read SEC document
June 28, 2024 Filed Jul 2, 2024 20:53 UTC
WOYS JAMESChief Operating Officer
GrantCommon Stock 69 $252.71 $17,436.99
Disclosure

SEC source: 0001179929-24-000108 · wk-form4_1719953617.xml · nonDerivative · entry 1

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,682

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: In accordance with the ESPP provisions, the purchase price is 85% of the closing price of the Issuer's common stock on June 28, 2024 of $297.30 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2024, the first date of the ESPP offering period, and (ii) June 28, 2024, the last trading day of the offering period).

F3 · balance_after: The shares vest as follows: 4,643 shares on March 1, 2025; 3,254 shares on March 1, 2026; and 1,549 shares on March 1, 2027. The remaining shares are vested.

Read SEC document
June 28, 2024 Filed Jul 2, 2024 20:52 UTC
Barlow Jeff D.Chief Legal Officer
GrantCommon Stock 69 $252.71 $17,436.99
Disclosure

SEC source: 0001179929-24-000107 · wk-form4_1719953571.xml · nonDerivative · entry 1

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,488

F1 · kind: The shares were acquired under the Molina Healthcare, Inc. 2019 Employee Stock Purchase Plan (the "ESPP").

F2 · price: In accordance with the ESPP provisions, the purchase price is 85% of the closing price of the Issuer's common stock on June 28, 2024 of $297.30 (which represents the lower market price of the Issuer's common stock as of (i) January 1, 2024, the first date of the ESPP offering period, and (ii) June 28, 2024, the last trading day of the offering period).

F3 · balance_after: The shares vest as follows: 3,738 shares on March 1, 2025; 2,563 shares on March 1, 2026; and 1,102 shares on March 1, 2027. The remaining shares are vested.

Read SEC document
May 22, 2024 Filed May 24, 2024 21:34 UTC
WOYS JAMESChief Operating Officer
SaleCommon Stock 100 $347.93 $34,793.00
Disclosure

SEC source: 0001179929-24-000095 · wk-form4_1716586439.xml · nonDerivative · entry 6

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,613

F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 20, 2024.

F7 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $347.92 to $347.93. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
May 22, 2024 Filed May 24, 2024 21:34 UTC
WOYS JAMESChief Operating Officer
SaleCommon Stock 350 $347.08 $121,478.00
Disclosure

SEC source: 0001179929-24-000095 · wk-form4_1716586439.xml · nonDerivative · entry 5

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 53,713

F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 20, 2024.

F6 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $346.74 to $347.58. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
May 22, 2024 Filed May 24, 2024 21:34 UTC
WOYS JAMESChief Operating Officer
SaleCommon Stock 1,743 $346.07 $603,200.01
Disclosure

SEC source: 0001179929-24-000095 · wk-form4_1716586439.xml · nonDerivative · entry 4

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,063

F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 20, 2024.

F5 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $345.70 to $346.70. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
May 22, 2024 Filed May 24, 2024 21:34 UTC
WOYS JAMESChief Operating Officer
SaleCommon Stock 5,607 $345.19 $1,935,480.33
Disclosure

SEC source: 0001179929-24-000095 · wk-form4_1716586439.xml · nonDerivative · entry 3

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,806

F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 20, 2024.

F4 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $344.69 to $345.68. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
May 22, 2024 Filed May 24, 2024 21:34 UTC
WOYS JAMESChief Operating Officer
SaleCommon Stock 1,450 $344.32 $499,264.00
Disclosure

SEC source: 0001179929-24-000095 · wk-form4_1716586439.xml · nonDerivative · entry 2

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,413

F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 20, 2024.

F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $343.64 to $344.62. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
May 22, 2024 Filed May 24, 2024 21:34 UTC
WOYS JAMESChief Operating Officer
SaleCommon Stock 750 $343.02 $257,265.00
Disclosure

SEC source: 0001179929-24-000095 · wk-form4_1716586439.xml · nonDerivative · entry 1

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,863

F1 · kind: The sale was made pursuant to Reporting Person's Rule 10b5-1 Trading Plan that was established on February 20, 2024.

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $342.61 to $343.46. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
May 21, 2024 Filed May 22, 2024 20:59 UTC
ROMNEY RONNADirector
SaleCommon Stock 250 $343.27 $85,817.50
Disclosure

SEC source: 0001179929-24-000093 · wk-form4_1716411558.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 16,945

F1 · price: Represents the actual selling price per share of all 250 shares.

F2 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:52 UTC GrantCommon Stock 136 $404.20 $54,971.20
Disclosure

SEC source: 0001179929-24-000076 · wk-form4_1712091119.xml · nonDerivative · entry 1

BRASIER BARBARA L · CIK 0001169490 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,688

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024 was $404.20, which resulted in a grant of 136 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 21:01 UTC GrantCommon Stock 136 $404.20 $54,971.20
Disclosure

SEC source: 0001179929-24-000083 · wk-form4_1712091677.xml · nonDerivative · entry 1

Lockhart Stephen H · CIK 0001856013 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,254

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 21:00 UTC GrantCommon Stock 136 $404.20 $54,971.20
Disclosure

SEC source: 0001179929-24-000082 · wk-form4_1712091626.xml · nonDerivative · entry 1

ZORETIC RICHARD C · CIK 0001263714 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 6,459

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024.

F4 · ownership.nature: All shares held by the Richard Charles Zoretic Revocable Living Trust.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:59 UTC GrantCommon Stock 136 $404.20 $54,971.20
Disclosure

SEC source: 0001179929-24-000081 · wk-form4_1712091533.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,343

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:57 UTC
WOLF DALE BDirector
GrantCommon Stock 136 $404.20 $54,971.20
Disclosure

SEC source: 0001179929-24-000080 · wk-form4_1712091409.xml · nonDerivative · entry 1

WOLF DALE B · CIK 0001228861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,003

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:55 UTC GrantCommon Stock 136 $404.20 $54,971.20
Disclosure

SEC source: 0001179929-24-000079 · wk-form4_1712091326.xml · nonDerivative · entry 1

ORLANDO STEVEN J · CIK 0001211493 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 18,837

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024.

F4 · ownership.nature: Shares are held by Orlando Family Trust.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:54 UTC
ROMNEY RONNADirector
GrantCommon Stock 136 $404.20 $54,971.20
Disclosure

SEC source: 0001179929-24-000078 · wk-form4_1712091252.xml · nonDerivative · entry 1

ROMNEY RONNA · CIK 0001206684 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · Held by trust

Disclosed balance after: 17,195

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024.

F4 · ownership.nature: All shares held by Ronna Romney Revocable Trust.

Read SEC document
April 01, 2024 Filed Apr 2, 2024 20:53 UTC GrantCommon Stock 136 $404.20 $54,971.20
Disclosure

SEC source: 0001179929-24-000077 · wk-form4_1712091174.xml · nonDerivative · entry 1

COOPERMAN DANIEL · CIK 0001205008 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,789

F1 · kind: Grant of stock under the Issuer's 2019 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

F2 · shares: The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2024, was $404.20, which resulted in a grant of 136 shares.

F3 · price: Represents the closing price of the Issuer's common stock on April 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:41 UTC
Barlow Jeff D.Chief Legal Officer
GrantCommon Stock 3,306 $387.21 $1,280,116.26
Disclosure

SEC source: 0001179929-24-000058 · wk-form4_1709689276.xml · nonDerivative · entry 4

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,419

F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

F6 · balance_after: The shares shall vest as follows: The 3,306 newly granted shares shall vest in one-third on each of March 1, 2025, March 1, 2026, and March 1, 2027. Additional shares shall vest as follows: 2,636 shares shall vest on March 1, 2025; 1,461 shares shall vest on March 1, 2026. The shares total includes an additional five shares to correct a clerical error. The remaining shares are vested.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:41 UTC
Barlow Jeff D.Chief Legal Officer
Tax withholdingCommon Stock 2,205 $387.21 $853,798.05
Disclosure

SEC source: 0001179929-24-000058 · wk-form4_1709689276.xml · nonDerivative · entry 3

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,113

F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 4,137 shares on March 1, 2024.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:41 UTC
Barlow Jeff D.Chief Legal Officer
Tax withholdingCommon Stock 6,133 $387.21 $2,374,758.93
Disclosure

SEC source: 0001179929-24-000058 · wk-form4_1709689276.xml · nonDerivative · entry 2

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,318

F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:41 UTC
Barlow Jeff D.Chief Legal Officer
GrantCommon Stock 11,473 $387.21 $4,442,460.33
Disclosure

SEC source: 0001179929-24-000058 · wk-form4_1709689276.xml · nonDerivative · entry 1

Barlow Jeff D. · CIK 0001555603 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,451

F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2021, which vested at the 170% achievement level based on the Company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:40 UTC
WOYS JAMESChief Operating Officer
GrantCommon Stock 4,649 $387.21 $1,800,139.29
Disclosure

SEC source: 0001179929-24-000057 · wk-form4_1709689226.xml · nonDerivative · entry 4

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,613

F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

F6 · balance_after: The shares shall vest as follows: The 4,649 newly granted shares shall vest in one-third on each of March 1, 2025, March 1, 2026, and March 1, 2027. Additional shares shall vest as follows: 3,093 shares shall vest on March 1, 2025; and 1,704 shares shall vest on March 1, 2026. The remaining shares are vested.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:40 UTC
WOYS JAMESChief Operating Officer
Tax withholdingCommon Stock 1,423 $387.21 $550,999.83
Disclosure

SEC source: 0001179929-24-000057 · wk-form4_1709689226.xml · nonDerivative · entry 3

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,964

F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 4,594 shares on March 1, 2024.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:40 UTC
WOYS JAMESChief Operating Officer
Tax withholdingCommon Stock 4,515 $387.21 $1,748,253.15
Disclosure

SEC source: 0001179929-24-000057 · wk-form4_1709689226.xml · nonDerivative · entry 2

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,387

F3 · shares: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:40 UTC
WOYS JAMESChief Operating Officer
GrantCommon Stock 11,473 $387.21 $4,442,460.33
Disclosure

SEC source: 0001179929-24-000057 · wk-form4_1709689226.xml · nonDerivative · entry 1

WOYS JAMES · CIK 0001213947 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,902

F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2021, which vested at the 170% achievement level based on the Company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:39 UTC
Bacon DebraEVP, Medicaid
Tax withholdingCommon Stock 170 $387.21 $65,825.70
Disclosure

SEC source: 0001179929-24-000056 · wk-form4_1709689176.xml · nonDerivative · entry 2

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,676

F3 · kind: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 491 shares on March 1, 2024.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

F4 · balance_after: The shares shall vest as follows: The 2,273 newly granted shares shall vest in one-third increments on each of March 1, 2025, March 1, 2026, and March 1, 2027. Additional shares shall vest as follows: 1, 231 shares shall vest on January 1, 2025; 491 shares shall vest on March 1, 2025; 245 shares shall vest on March 1, 2026; 531 shares shall vest on July 1, 2024; 530 shares shall vest on July 1, 2025; and 529 shares shall vest on July 1, 2026. The remainder of the shares are vested.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:39 UTC
Bacon DebraEVP, Medicaid
GrantCommon Stock 2,273 $387.21 $880,128.33
Disclosure

SEC source: 0001179929-24-000056 · wk-form4_1709689176.xml · nonDerivative · entry 1

Bacon Debra · CIK 0002010075 · EVP, Medicaid

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,846

F1 · kind: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:39 UTC
HEBERT MAURICEChief Accounting Officer
GrantCommon Stock 258 $387.21 $99,900.18
Disclosure

SEC source: 0001179929-24-000055 · wk-form4_1709689139.xml · nonDerivative · entry 5

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,866

F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

F6 · balance_after: The shares shall vest as follows: The 774 newly granted shares shall vest in one-third on each of March 1, 2025, March 1, 2026, and March 1, 2027. Additional shares shall vest as follows: 643 shares shall vest on March 1, 2025; and 243 shares shall vest on March 1, 2026. The remaining shares are vested.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:39 UTC
HEBERT MAURICEChief Accounting Officer
GrantCommon Stock 516 $387.12 $199,753.92
Disclosure

SEC source: 0001179929-24-000055 · wk-form4_1709689139.xml · nonDerivative · entry 4

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,608

F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:39 UTC
HEBERT MAURICEChief Accounting Officer
Tax withholdingCommon Stock 516 $387.21 $199,800.36
Disclosure

SEC source: 0001179929-24-000055 · wk-form4_1709689139.xml · nonDerivative · entry 3

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,092

F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 1,276 shares on March 1, 2024.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:39 UTC
HEBERT MAURICEChief Accounting Officer
Tax withholdingCommon Stock 450 $387.21 $174,244.50
Disclosure

SEC source: 0001179929-24-000055 · wk-form4_1709689139.xml · nonDerivative · entry 2

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,608

F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:39 UTC
HEBERT MAURICEChief Accounting Officer
GrantCommon Stock 1,530 $387.21 $592,431.30
Disclosure

SEC source: 0001179929-24-000055 · wk-form4_1709689139.xml · nonDerivative · entry 1

HEBERT MAURICE · CIK 0001267043 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,058

F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2021, which vested at the 170% achievement level based on the Company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:38 UTC
Keim Mark LowellChief Financial Officer
GrantCommon Stock 5,165 $387.12 $1,999,474.80
Disclosure

SEC source: 0001179929-24-000054 · wk-form4_1709689081.xml · nonDerivative · entry 4

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,594

F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

F6 · balance_after: The shares shall vest as follows: The 5,165 newly granted shares shall vest in one-third increments on each of March 1, 2025, March 1, 2026, and March 1, 2027. The additional shares shall vest as follows: 3,551 shares shall vest on March 1, 2025; and 1,948 shares shall vest on March 1, 2026. The remainder of the shares are vested.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:38 UTC
Keim Mark LowellChief Financial Officer
Tax withholdingCommon Stock 2,507 $387.21 $970,735.47
Disclosure

SEC source: 0001179929-24-000054 · wk-form4_1709689081.xml · nonDerivative · entry 3

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,429

F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 5,651 shares on March 1, 2024.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:38 UTC
Keim Mark LowellChief Financial Officer
Tax withholdingCommon Stock 7,658 $387.21 $2,965,254.18
Disclosure

SEC source: 0001179929-24-000054 · wk-form4_1709689081.xml · nonDerivative · entry 2

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,936

F3 · shares: Shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:38 UTC
Keim Mark LowellChief Financial Officer
GrantCommon Stock 16,063 $387.21 $6,219,754.23
Disclosure

SEC source: 0001179929-24-000054 · wk-form4_1709689081.xml · nonDerivative · entry 1

Keim Mark Lowell · CIK 0001690677 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,594

F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2021, which vested at the 170% achievement level based on the Company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:37 UTC
Zubretsky Joseph MDirector · President & CEO
GrantCommon Stock 16,735 $387.21 $6,479,959.35
Disclosure

SEC source: 0001179929-24-000052 · wk-form4_1709689020.xml · nonDerivative · entry 4

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,952

F5 · shares: Grant of restricted stock under the Issuer's 2019 Equity Incentive Plan.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

F6 · balance_after: The shares shall vest as follows: The 16,735 newly granted shares shall vest in one-third on each of March 1, 2025, March 1, 2026, and March 1, 2027. Additional shares shall vest as follows: 13,960 shares shall vest on March 1, 2025; and 7,548 shares shall vest on March 1, 2026. The remaining shares are vested.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:37 UTC
Zubretsky Joseph MDirector · President & CEO
Tax withholdingCommon Stock 27,374 $387.21 $10,599,486.54
Disclosure

SEC source: 0001179929-24-000052 · wk-form4_1709689020.xml · nonDerivative · entry 3

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 333,217

F4 · shares: The shares were applied to the payment of withholding taxes arising in connection with the vesting of 22,960 shares on March 1, 2024.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:37 UTC
Zubretsky Joseph MDirector · President & CEO
Tax withholdingCommon Stock 32,069 $387.21 $12,417,437.49
Disclosure

SEC source: 0001179929-24-000052 · wk-form4_1709689020.xml · nonDerivative · entry 2

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 360,591

F3 · shares: The shares were applied to payment of withholding taxes in connection with vesting of the above-mentioned performance stock units.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 6, 2024 01:37 UTC
Zubretsky Joseph MDirector · President & CEO
GrantCommon Stock 68,844 $387.21 $26,657,085.24
Disclosure

SEC source: 0001179929-24-000052 · wk-form4_1709689020.xml · nonDerivative · entry 1

Zubretsky Joseph M · CIK 0001320929 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,660

F1 · shares: Shares issued in settlement of performance stock units granted on March 1, 2021, which vested at the 170% achievement level based on the Company's averaged achievement of adjusted net income per share in the three fiscal years of 2021, 2022, and 2023.

F2 · price: Represents the closing price of the Issuer's common stock on March 1, 2024.

Read SEC document
February 20, 2024 Filed Feb 20, 2024 21:56 UTC SaleCommon Stock 20 $403.06 $8,061.20
Disclosure

SEC source: 0001179929-24-000045 · wk-form4_1708466157.xml · nonDerivative · entry 4

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,207

F4 · price: Represents the selling price per share of all 20 shares.

Read SEC document
February 20, 2024 Filed Feb 20, 2024 21:56 UTC SaleCommon Stock 180 $402.03 $72,365.40
Disclosure

SEC source: 0001179929-24-000045 · wk-form4_1708466157.xml · nonDerivative · entry 3

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,227

F3 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $401.985 to $402.100. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
February 20, 2024 Filed Feb 20, 2024 21:56 UTC SaleCommon Stock 475 $401.23 $190,584.25
Disclosure

SEC source: 0001179929-24-000045 · wk-form4_1708466157.xml · nonDerivative · entry 2

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,407

F2 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $400.77 to $401.39. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document
February 20, 2024 Filed Feb 20, 2024 21:56 UTC SaleCommon Stock 325 $400.12 $130,039.00
Disclosure

SEC source: 0001179929-24-000045 · wk-form4_1708466157.xml · nonDerivative · entry 1

Schapiro Richard M · CIK 0001649773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,882

F1 · price: Price is the volume weighted average selling price of all sales by the Reporting Person on the transaction date within a one-dollar range. Actual prices ranged from $399.43 to $400.36. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.